HCPCS codes / M / M1413
M1413
Patients who had a positive pd-l1 biomarker expression test result prior to the initiation of first-line immune checkpoint inhibitor therapy
- Code type
- HCPCS Level II
- Coverage
- Carrier judgment
- BETOS category
- Z2
- Pricing indicator
- 00
- Effective date
- 20250101
Verify before billing. Confirm against current official CMS HCPCS files and your payer's rules before clinical or claims use.